These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36416475)

  • 1. Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy.
    Kawarada O; Zen K; Hozawa K; Obara H; Matsubara K; Yamamoto Y; Doijiri T; Tamai N; Ito S; Higashimori A; Kawasaki D; Doi H; Matsushita K; Tsukahara K; Noda K; Shimpo M; Tsuda Y; Sonoda S; Taniguchi T; Waseda K; Munehisa M; Taguchi E; Kinjo T; Sasaki Y; Yuba K; Yamaguchi S; Nakagami T; Ayabe S; Sakamoto S; Yagyu T; Ogata S; Nishimura K; Motomura H; Noguchi T; Ishihara M; Ogawa H; Yasuda S
    J Endovasc Ther; 2024 Aug; 31(4):622-633. PubMed ID: 36416475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinterventions in Patients with Claudication and Chronic Limb Threatening Ischemia.
    Mohamedali A; Kiwan G; Kim T; Zhang Y; Zhuo H; Tonnessen B; Dardik A; Chaar CIO
    Ann Vasc Surg; 2022 Feb; 79():56-64. PubMed ID: 34656724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.
    Giannopoulos S; Secemsky EA; Mustapha JA; Adams G; Beasley RE; Pliagas G; Armstrong EJ
    J Endovasc Ther; 2020 Oct; 27(5):714-725. PubMed ID: 32618486
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.
    Perlander A; Jivegård L; Nordanstig J; Svensson M; Österberg K
    J Vasc Surg; 2020 Dec; 72(6):1987-1995. PubMed ID: 32276010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
    Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Institutional Volume on Critical In-Hospital Complications Adjusted for Patient- and Limb-Related Characteristics: An Analysis of a Nationwide Japanese Registry of Endovascular Interventions for PAD.
    Iida O; Takahara M; Kohsaka S; Soga Y; Fujihara M; Mano T; Shinke T; Amano T; Ikari Y
    J Endovasc Ther; 2020 Oct; 27(5):739-748. PubMed ID: 32436810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Endovascular 30-Day Outcomes for Critical Limb Threatening Ischemia Relative to Surgical Bypass Grafting.
    Latz CA; Boitano L; Wang LJ; Pendleton AA; DeCarlo C; Sumpio B; Schwartz S; Srivastava S; Dua A
    Vasc Endovascular Surg; 2021 Jul; 55(5):441-447. PubMed ID: 33602047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
    Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening Ischemia.
    Utsunomiya M; Takahara M; Iida O; Soga Y; Hata Y; Shiraki T; Nagae A; Kato T; Kobayashi N; Suematsu N; Tasaki J; Horie K; Uchida D; Kodama A; Azuma N; Nakamura M
    J Endovasc Ther; 2020 Aug; 27(4):584-594. PubMed ID: 32431246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of major adverse lower limb events in patients with tissue loss secondary to critical limb-threatening ischemia.
    Vosgin-Dinclaux V; Bertucat P; Dari L; Webster C; Foussard N; Mohammedi K; Ducasse E; Caradu C
    Cardiovasc Revasc Med; 2024 Jul; 64():34-41. PubMed ID: 38350775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates.
    Madabhushi V; Davenport D; Jones S; Khoudoud SA; Orr N; Minion D; Endean E; Tyagi S
    J Vasc Surg; 2021 Sep; 74(3):771-779. PubMed ID: 33775749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infra-inguinal bypass surgery vs endovascular revascularization for chronic limb-threatening ischemia in average- and high-risk patients.
    Morisaki K; Matsuda D; Guntani A; Kinoshita G; Yoshino S; Inoue K; Honma K; Yamaoka T; Mii S; Yoshizumi T
    J Vasc Surg; 2024 Jul; 80(1):204-212.e3. PubMed ID: 38522583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions.
    Alameddine D; Damara FA; Pinto Rodriguez P; Huttler J; Slade MD; Arhuidese I; Aboian E; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Jun; 103():47-57. PubMed ID: 38387798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of drug-eluting stents in patients with critical limb ischemia and infrapopliteal arterial disease: a real-world single-center experience.
    AbuRahma AF; Beasley M; Davis M; Adams E; Lee A; Shapiro J; Dean LS; Davis E
    J Vasc Surg; 2021 Nov; 74(5):1619-1625. PubMed ID: 34182023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia.
    Anjorin AC; Marcaccio CL; Patel PB; Wang SX; Rowe V; Aulivola B; Wyers MC; Schermerhorn ML
    J Vasc Surg; 2022 Nov; 76(5):1335-1346.e7. PubMed ID: 35768062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.